RxDoctor Payments Data

Jensen Swampillai, DO

Physical Medicine & Rehabilitation · East Lansing, MINPI 1891287686

Payments from drug & device makers

$772in general payments, 2019–2025

Across 22 payments — averaging $35.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$149
  • Globus Medical$132
  • Medtronic$121
  • AbbVie$102
  • Averitas Pharma Inc.$37
  • Pfizer$32
  • plus $197 from 10 others

What the payments were for

  • Food & beverage$772100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$772 in reported general payments places this provider in the 65th percentile of 469 physical medicine & rehabilitation providers in Michigan.

See all physical medicine & rehabilitation providers in Michigan

Medicare billing

Part B allowed, 2024
$49,202
Medicare patients
186
Services billed
1,209

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OxycontinOxycodone Hcl17$10,235
Xtampza ErOxycodone Myristate11$5,725
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen132$2,671
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen151$2,075
Pregabalin52$880
Gabapentin53$634
Morphine Sulfate ErMorphine Sulfate29$611
Oxycodone Hcl35$542
Cyclobenzaprine Hcl33$365
Methocarbamol28$160
Duloxetine Hcl13$129
Meloxicam45$106
Ibuprofen14$57
Naproxen13$53

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Xtampza Er$19$5,72511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 65th percentile of 469 physical medicine & rehabilitation providers in Michigan.

Other physical medicine & rehabilitation in East Lansing

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →